Business Description
Enzolytics Inc
NAICS : 325412
SIC : 2834
Compare
Compare
Traded in other countries / regions
ENZC.USA
Description
Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies: Immunotherapy, immune modulators, fully human monoclonal antibodies and an artificial intelligence (AI) platform for heath care developments. The Company has clinically tested anti HIV therapeutics. Additionally, the Company has created a proprietary cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Piotroski F-Score | 0/9 | |||||
| Altman Z-Score | 0 | |||||
| Beneish M-Score | 0 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.86 | |||||
| 9-Day RSI | 21.16 | |||||
| 14-Day RSI | 23.26 | |||||
| 6-1 Month Momentum % | -36.06 | |||||
| 12-1 Month Momentum % | -71.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ENZC
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.046 | ||
| EPS (TTM) ($) | -170.268 | ||
| Beta | 0.85 | ||
| Volatility % | 84.53 | ||
| 14-Day RSI | 23.26 | ||
| 14-Day ATR ($) | 0.0047 | ||
| 20-Day SMA ($) | 0.038535 | ||
| 12-1 Month Momentum % | -71.23 | ||
| 52-Week Range ($) | 0.027 - 0.2032 | ||
| Shares Outstanding (Mil) | 2,438.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enzolytics Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enzolytics Inc Analysis
Share your researchHeadlines
See More
No news.